Volitionrx (VNRX) Share-based Compensation (2011 - 2025)
Volitionrx (VNRX) posted Share-based Compensation of $1.6 million for Q4 2025, up 524.8% on a QoQ basis from -$371906.0 in Q2 2025, and up 1807.77% year-over-year from $82812.0 in Q4 2024.
Volitionrx (VNRX) Share-based Compensation (2011 - 2025) Analysis & Trends
Volitionrx's Share-based Compensation history runs 15 years deep, the most recent figure standing at $1.6 million for Q4 2025.
- Quarterly Share-based Compensation rose 1807.77% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (up 182.15% YoY) and the FY2025 annual result came in at $1.7 million, up 1143.19% from the prior year.
- Share-based Compensation was $1.6 million for Q4 2025 at Volitionrx, up from -$371906.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $3.0 million in Q4 2022 and bottomed at -$371906.0 in Q2 2025.
- A 5-year average of $607112.9 and a median of $537980.0 in 2023 frame the typical range for Share-based Compensation.
- Peak annual rise in Share-based Compensation reached 14641.15% in 2025, while the deepest fall reached 278.76% in 2025.
- Volitionrx's Share-based Compensation stood at $276729.0 in 2021, then soared by 971.22% to $3.0 million in 2022, then slumped by 95.83% to $123647.0 in 2023, then sank by 33.03% to $82812.0 in 2024, then soared by 1807.77% to $1.6 million in 2025.
- Business Quant data shows VNRX's Share-based Compensation at $1.6 million in Q4 2025, -$371906.0 in Q2 2025, and $451374.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 35.80 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn | 35.00 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn | 35.12 Mn |
| 10 | Volitionrx | 90,088.41 | -1.03 Mn | - | 1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.58 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Jun 30, 2025 | -371,906.00 |
| Jun 30, 2025 | -371,906.00 |
| Mar 31, 2025 | 451,374.00 |
| Mar 31, 2025 | 451,374.00 |
| Dec 31, 2024 | 82,812.00 |
| Dec 31, 2024 | 82,812.00 |
| Sep 30, 2024 | 323,539.00 |
| Sep 30, 2024 | 323,539.00 |
| Jun 30, 2024 | 208,046.00 |
| Jun 30, 2024 | 208,046.00 |
| Mar 31, 2024 | 3,062.00 |
| Mar 31, 2024 | 3,062.00 |
| Dec 31, 2023 | 123,647.00 |
| Dec 31, 2023 | 123,647.00 |
| Sep 30, 2023 | 537,980.00 |
| Sep 30, 2023 | 537,980.00 |
| Jun 30, 2023 | 592,174.00 |
| Jun 30, 2023 | 592,174.00 |